Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 32
Filter
1.
Eur J Clin Microbiol Infect Dis ; 35(2): 279-84, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26690071

ABSTRACT

Few data have been published regarding the epidemiology and outcome of infective endocarditis (IE) in patients with chronic hepatic disease (CHD). A retrospective analysis of the Studio Endocarditi Italiano (SEI) database was performed to evaluate the epidemiology and outcome of CHD+ patients compared with CHD- patients. The diagnosis of IE was defined in accordance with the modified Duke criteria. Echocardiography, diagnosis, and treatment procedures were in accordance with current clinical practice. Among the 1722 observed episodes of IE, 300 (17.4 %) occurred in CHD+ patients. The cause of CHD mainly consisted of chronic viral infection. Staphylococcus aureus was the most common bacterial species in CHD+ patients; the frequency of other bacterial species (S. epidermidis, streptococci, and enterococci) were comparable among the two groups. The percentage of patients undergoing surgery for IE was 38.9 in CHD+ patients versus 43.7 in CHD- patients (p = 0.06). Complications were more common among CHD+ patients (77 % versus 65.3 %, p < 0.001); embolization (43.3 % versus 26.1 %, p < 0.001) and congestive heart failure (42 % versus 34.1 %, p = 0.01) were more frequent among CHD+ patients. Mortality was comparable (12.5 % in CHD- and 15 % in CHD+ patients). At multivariable analysis, factors associated with hospital-associated mortality were having an infection sustained by S. aureus, a prosthetic valve, diabetes and a neoplasia, and CHD. Being an intravenous drug user (IVDU) was a protective factor and was associated with a reduced death risk. CHD is a factor worsening the prognosis in patients with IE, in particular in patients for whom cardiac surgery was required.


Subject(s)
Endocarditis, Bacterial/epidemiology , Endocarditis, Bacterial/microbiology , Liver Diseases/epidemiology , Liver Diseases/microbiology , Adult , Aged , Endocarditis, Bacterial/drug therapy , Endocarditis, Bacterial/mortality , Female , Hospital Mortality , Humans , Italy/epidemiology , Liver Diseases/virology , Male , Middle Aged , Prognosis , Prospective Studies , Prosthesis-Related Infections/microbiology , Retrospective Studies , Risk Factors , Staphylococcal Infections/epidemiology , Staphylococcal Infections/microbiology , Staphylococcus aureus/isolation & purification , Staphylococcus epidermidis/isolation & purification
2.
Infection ; 40(5): 527-35, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22711599

ABSTRACT

BACKGROUND: The characteristics of patients with infective endocarditis (IE) vary significantly by region of the world. The aim of this study was to evaluate the contemporary epidemiology, characteristics, and outcome of IE in a large, nationwide cohort of Italian patients. METHODS: We conducted a prospective, observational study at 24 medical centers in Italy, including all the consecutive patients with a definite or possible diagnosis of IE (modified Duke criteria) admitted from January 2004 through December 2009. A number of clinical variables were collected through an electronic case report form and analyzed to comprehensively delineate the features of IE. We report the data on patients with definite IE. RESULTS: A total of 1,082 patients with definite IE were included. Of these, 753 (69.6%) patients had infection on a native valve, 277 (25.6%) on a prosthetic valve, and 52 (4.8%) on an implantable electronic device. Overall, community-acquired (69.2%) was more common than nosocomial (6.2%) or non-nosocomial (24.6%) health care-associated IE. Staphylococcus aureus was the most common pathogen (22.0%). In-hospital mortality was 15.1%. From the multivariate analysis, congestive heart failure (CHF), stroke, prosthetic valve infection, S. aureus, and health care-associated acquisition were independently associated with increased in-hospital mortality, while surgery was associated with decreased mortality. CONCLUSIONS: The current mortality of IE remains high, and is mainly due to its complications, such as CHF and stroke.


Subject(s)
Endocarditis, Bacterial/epidemiology , Adult , Aged , Aged, 80 and over , Analysis of Variance , Female , Humans , Italy/epidemiology , Male , Middle Aged , Odds Ratio , Prospective Studies , Risk Factors , Treatment Outcome , Young Adult
6.
J Cardiovasc Surg (Torino) ; 39(3): 337-42, 1998 Jun.
Article in English | MEDLINE | ID: mdl-9678557

ABSTRACT

OBJECTIVE: To review intra- and postoperative data regarding surgical reconstruction of the aortic arch performed at our cardiosurgical centre during the past four years, and thus to deepen understanding of neurologic morbidity and of what constitutes the most effective neuroprotection. EXPERIMENTAL DESIGN: Retrospective study. SETTING: Regional University Hospital. PATIENTS: 29 patients who underwent reconstruction of aneurysm or dissection of the aortic arch. Intervention. Surgical replacement of the diseased aorta during deep hypothermia, alone or with selective cerebral perfusion (antegrade or retrograde). MEASURES: Overall mortality rate, neurologic morbidity rate, duration of extracorporeal circulation, of hypothermic circulatory arrest or of selective cerebral perfusion. Evaluation of the importance to neurological outcome of age, modality of operation (emergency or routine), biochemical parameters (glycemia, hematocrit) and perfusion technique. Recording of postoperative time of arousal, and possible correlation with length of selective cerebral perfusion. RESULTS: We observed a mortality rate of 39% (11 deaths) and a neurologic morbidity rate of 34%. Hypothermic circulatory arrest alone did not assure valid neuroprotection (5 cases, all with severe neurologic impairment), while better results were obtained with selective cerebral perfusion, especially antegrade (14 cases, with only 7% of neurologic morbidity rate). Hyperglycemia (>250 mg%) proved to be significantly associated (p=0.002) with increased incidence of adverse neurologic outcome, and the same association was observed between emergency status and adverse neurologic outcome (p=0.002). Moreover, we found an unexpected linear correlation between time of selective cerebral perfusion and postoperative time of arousal (r=0.728, p=0.000). CONCLUSIONS: Deep hypothermic circulatory arrest with selective cerebral perfusion currently represent a valid therapeutic option for brain preservation during reconstruction of the aortic arch in adults. It is mandatory to carry out a tight control of perfusion parameters (flow, pressures and temperature gradients) and biochemical variables (avoidance of hyperglycemia and modified ultrafiltration for fluid balance).


Subject(s)
Aortic Aneurysm, Thoracic/surgery , Aortic Dissection/surgery , Brain Ischemia/prevention & control , Postoperative Complications/prevention & control , Adult , Aged , Aged, 80 and over , Aorta, Thoracic , Extracorporeal Circulation , Female , Heart Arrest, Induced , Humans , Male , Middle Aged , Perfusion , Retrospective Studies , Treatment Outcome
7.
Pharmacol Res ; 37(2): 115-22, 1998 Feb.
Article in English | MEDLINE | ID: mdl-9572066

ABSTRACT

The effects of L-carnitine on cardiac performance after open heart surgery were evaluated in a balanced, placebo-controlled, double-blind study in 38 patients. Preoperative haemodynamic status was good in all of them. Seventeen subjects underwent mitral valve replacement and 19 patients coronary artery bypass grafting. Five grams L-carnitine were given intravenously over 2 h, twice daily for 5 consecutive days; moreover, 10 g L-carnitine in 1500 ml cardioplegia were administered through the aortic root after aortic cross-clamping. Surgery was always planned on treatment day 3. The post-ischaemic functional recovery of the heart was assessed by clinical parameters, as well as by biochemical and ultrastructure evaluations on biopsy specimens. No differences were found between the control and the treatment group with respect to all clinical parameters of cardiac performance after cardiopulmonary bypass. At anaesthesia induction, serum carnitine was significantly increased in treated patients, but carnitine concentrations in the right atrial biopsy obtained just before aortic declamping were similar in the two groups. In patients with mitral valve replacement, L-carnitine therapy was associated with significantly higher concentrations of pyruvate, ATP and creatine phosphate in papillary muscle. Glycogen levels were also higher in the treated group, but the difference was not statistically significant. Myocardial ultrastructure on septal biopsies, obtained within 5 min from weaning from extracorporeal circulation, showed better preservation scores for all considered parameters (nucleus, sarcoplasmic reticulum, mitochondria and cellular oedema) in the treated subjects, although the difference reached statistical significance only for nuclei. When biochemical and ultrastructural data are considered, these findings suggest that L-carnitine improves myocardial metabolism. However, it cannot be concluded that L-carnitine provides an advantageous support therapy for well-compensated patients requiring cardiac surgery. In contrast, the positive effects of L-carnitine on cardiac recovery after bypass might become clinically relevant in the surgical setting for haemodynamically compromised patients, in which further investigations are required.


Subject(s)
Cardiac Surgical Procedures/methods , Carnitine/therapeutic use , Heart/drug effects , Myocardium/metabolism , Aged , Atrial Function, Right/physiology , Biopsy , Cardiopulmonary Bypass , Carnitine/blood , Coronary Artery Bypass , Double-Blind Method , Female , Heart Atria/metabolism , Heart Valve Prosthesis Implantation , Humans , Male , Middle Aged , Mitral Valve , Myocardium/ultrastructure , Placebos
9.
Epilepsia ; 38(6): 702-7, 1997 Jun.
Article in English | MEDLINE | ID: mdl-9186253

ABSTRACT

PURPOSE: This study was conducted to determine whether vigabatrin affects in vivo indices of hepatic microsomal enzyme activity and the pharmacokinetics of steroid oral contraceptives in healthy subjects. METHODS: Under double-blind conditions, 13 female healthy volunteers received, in random order and with a washout interval of > or = 4 weeks, two oral 4-week treatments with vigabatrin (VGB) (maintenance dosage, 3,000 mg daily) and placebo, respectively. The clearance and half-life of antipyrine (a broad marker of drug oxidation capacity), the urinary excretion of 6-beta-hydroxycortisol (a selective marker of cytochrome CYP3A-mediated oxidation), and the activity of serum gamma-glutamyltransferase (a nonspecific index of microsomal enzyme activity) were determined after 3 weeks of each treatment. The single-dose kinetics of a combined oral contraceptive containing 30 micrograms ethinyl estradiol and 150 micrograms levonorgestrel were also determined after 3 weeks of treatment by specific radioimmunologic assays. RESULTS: VGB treatment had no influence on antipyrine clearance (28 +/- 5.6 vs. 30 +/- 4.5 ml/h/kg on placebo), antipyrine half-life (15.5 +/- 3.5 vs. 14.1 +/- 2.1 h), urinary 6-beta-hydroxycortisol excretion (488 +/- 164 vs. 470 +/- 228 nmol/ day), 6-beta-hydroxycortisol-to-cortisol concentration ratio (6.8 +/- 3.1 vs. 6.1 +/- 3.1) and serum gamma-glutamyltransferase activity (12 +/- 3 vs. 11 +/- 3 IU/L). No difference in pharmacokinetic parameters between VGB and placebo sessions were found for ethinyl estradiol (half-life, 12.5 +/- 3.2 vs. 13.9 +/- 3.2 h; AUC, 874 +/- 301 vs. 939 +/- 272 ng/ L/h) and levonorgestrel (half-life, 17.7 +/- 5.2 vs. 23.1 +/- 9.8 h; AUC, 27.5 +/- 9.6 vs. 30.0 +/- 12.0 micrograms/L/h). Two subjects, however, showed a 50 and a 39% reduction in ethinyl estradiol AUC during VGB treatment. CONCLUSIONS: At therapeutic dosages, VGB did not modify in vivo indices of hepatic microsomal enzyme activity and did not interfere significantly with the CYP3A-mediated metabolism of ethinyl estradiol and levonorgestrel. Based on these data, VGB is unlikely to affect consistently the efficacy of steroid oral contraceptives or interact pharmacokinetically with drugs that are eliminated mainly by oxidative pathways, particularly those involving cytochrome CYP3A.


Subject(s)
Anticonvulsants/pharmacokinetics , Aryl Hydrocarbon Hydroxylases , Contraceptives, Oral, Combined/pharmacokinetics , Estradiol Congeners/pharmacokinetics , Levonorgestrel/pharmacokinetics , Microsomes, Liver/enzymology , gamma-Aminobutyric Acid/analogs & derivatives , Adult , Anticonvulsants/pharmacology , Antipyrine/blood , Antipyrine/metabolism , Contraceptives, Oral, Combined/blood , Cytochrome P-450 CYP3A , Cytochrome P-450 Enzyme System/drug effects , Cytochrome P-450 Enzyme System/metabolism , Double-Blind Method , Drug Interactions , Enzyme Induction/drug effects , Estradiol Congeners/blood , Ethinyl Estradiol/blood , Ethinyl Estradiol/pharmacokinetics , Female , Half-Life , Humans , Levonorgestrel/blood , Microsomes, Liver/drug effects , Oxidoreductases, N-Demethylating/drug effects , Oxidoreductases, N-Demethylating/metabolism , Placebos , Vigabatrin , gamma-Aminobutyric Acid/pharmacokinetics , gamma-Aminobutyric Acid/pharmacology , gamma-Glutamyltransferase/blood
10.
Ann Thorac Surg ; 63(2): 533-5, 1997 Feb.
Article in English | MEDLINE | ID: mdl-9033334

ABSTRACT

Cardiopulmonary failure occurred in a 62-year-old patient a few hours after emergency cardiac retransplantation. Venoarterial extracorporeal membrane oxygenation was required to support biventricular dysfunction; thereafter, inhaled nitric oxide was given for residual hypoxemia and pulmonary hypertension. We report survival after venoarterial extracorporeal membrane oxygenation and inhaled nitric oxide treatment for both heart and lung failure in a heart recipient.


Subject(s)
Extracorporeal Membrane Oxygenation , Heart Transplantation , Hypertension, Pulmonary/drug therapy , Hypoxia/drug therapy , Nitric Oxide/therapeutic use , Postoperative Complications/therapy , Ventricular Dysfunction, Right/therapy , Humans , Male , Middle Aged
11.
Chest ; 105(4): 1275-7, 1994 Apr.
Article in English | MEDLINE | ID: mdl-8162769

ABSTRACT

Sternal osteomyelitis due to Aspergillus fumigatus after cardiac surgery occurred in two nonimmunosuppressed patients. The clinical features of the infection were markedly different in the two cases. In the first patient, sepsis showed a late and insidious onset followed by slow progression. In the second case, fungi were isolated from wound swabs within a few days of surgery and the clinical picture showed acute onset and rapid progression. Only a few cases of sternal osteomyelitis due to Aspergillus have been described previously after cardiac surgery. Aspergillus infection should be considered in the differential diagnosis of mediastinitis after cardiac surgery, especially in a clinical setting of otherwise unexplained sepsis or nonhealing wound despite apparently adequate treatment.


Subject(s)
Aspergillosis/etiology , Aspergillus fumigatus , Cardiac Surgical Procedures/adverse effects , Osteomyelitis/etiology , Sternum , Surgical Wound Infection/diagnosis , Aged , Aspergillosis/diagnosis , Female , Humans , Male , Middle Aged , Osteomyelitis/diagnosis , Sternum/surgery
12.
Drugs Exp Clin Res ; 20(3): 115-20, 1994.
Article in English | MEDLINE | ID: mdl-7956718

ABSTRACT

The influence of extrahepatic neoplastic disease on the biotransformation of theophylline was assessed by comparing the pharmacokinetic and metabolic profile of the drug in six patients with advanced breast or bronchial carcinoma, without detectable liver metastases, and in six appropriately matched control subjects. Each subject was given a single dose of theophylline (5 mg/kg) in oral solution; blood and urinary samples were collected for up to 24 h after dosing. Theophylline was absorbed rapidly in all subjects and within 2 h reached comparable peak concentrations in both groups (cancer patients: 57.8 +/- 14.4 mumol/l; controls; 65.0 +/- 10.6 mumol/l; N.S., means +/- s.d.). No significant differences were observed between cancer patients and controls for theophylline apparent volume of distribution (0.44 +/- 0.07 vs 0.40 +/- 0.06 l/kg), total body clearance (40.8 +/- 12.8 vs 34.8 +/- 13.0 ml kg-1 h-1) and elimination half-life (8.0 +/- 1.6 vs 8.5 +/- 1.8 h). The excretion of the major metabolites 3-methyl-xanthine and 1,3-dimethyl-uric acid was also very similar in the two groups. These data do not provide any evidence for an altered rate or pattern of theophylline biotransformation in patients with advanced extrahepatic neoplastic disease.


Subject(s)
Breast Neoplasms/metabolism , Lung Neoplasms/metabolism , Theophylline/pharmacokinetics , Adult , Biotransformation , Breast Neoplasms/complications , Female , Half-Life , Humans , Immunoenzyme Techniques , Intestinal Absorption , Liver Neoplasms/secondary , Lung Neoplasms/complications , Male , Middle Aged , Theophylline/blood , Theophylline/urine
13.
Minerva Anestesiol ; 59(3): 129-32, 1993 Mar.
Article in Italian | MEDLINE | ID: mdl-8515853

ABSTRACT

The authors report their experience with the management of patients with sickle cell trait undergoing open heart surgery. They focus their attention mainly on those factors potentially able to precipitate episodes of sickling, i.e. hypoxia, hypothermia, vascular stasis and acidosis.


Subject(s)
Cardiac Surgical Procedures , Extracorporeal Circulation , Sickle Cell Trait , Adult , Cardiac Surgical Procedures/adverse effects , Extracorporeal Circulation/adverse effects , Female , Humans , Male , Middle Aged , Postoperative Complications/prevention & control
14.
Drugs Exp Clin Res ; 19(1): 33-9, 1993.
Article in English | MEDLINE | ID: mdl-8223138

ABSTRACT

Levodropropizine is the l-isomer of dropropizine, a racemic drug widely used as a cough suppressant. Compared with the racemate, levodropropizine retains equal antitussive activity but exhibits considerably lower central nervous system (CNS) depressant effects in animal models. In order to assess whether the same differential pharmacodynamic profile also applies to man, a double-blind placebo-controlled study was carried out to investigate the effects of single oral doses (60 and 120 mg) of levodropropizine and dropropizine on subjective alertness (scored on visual analogue scales), general tolerability and psychomotor function tests (cancellation, tapping, choice reaction times and critical flicker fusion frequency) in ten normal volunteers. Treatments were administered in random sequence at intervals of at least one week, evaluation procedures being carried out at times 0, 1, 2, 3, 4, 6 and 8 h after dosing. Following intake of a 60 mg levodropizine dose, subjective effects and objective estimates of psychomotor function were superimposable to those recorded after placebo. There was a trend for 60 mg dropropizine and 120 mg levodropropizine to produce detrimental effects at occasional evaluations, although the changes associated with these treatments could not be differentiated from placebo on the basis of most subjective scores and psychomotor function tests. Conversely, administration of 120 mg dropropizine was consistently associated with subjective CNS impairment and with reduced performance (compared to baseline) in recognition time, critical flicker fusion thresholds and possibly tapping rate, for up to three hours after dosing. These data are consistent with evidence that racemic dropropizine adversely affects central nervous system function to a greater extent compared with the levo-isomer.


Subject(s)
Antitussive Agents/pharmacology , Propylene Glycols/pharmacology , Psychomotor Performance/drug effects , Adult , Cognition/drug effects , Double-Blind Method , Female , Flicker Fusion/drug effects , Humans , Male , Reaction Time/drug effects , Stereoisomerism
15.
Int J Clin Pharmacol Ther Toxicol ; 30(9): 331-5, 1992 Sep.
Article in English | MEDLINE | ID: mdl-1428296

ABSTRACT

L-alpha-glycerylphosphorylcholine (alpha-GPC) is a recently developed cognitive enhancer whose mode of action is considered to involve the release of free choline, which is then utilized for acetylcholine and phosphatidylcholine biosynthesis in the brain. The purpose of this study was to evaluate the profile of free plasma choline levels following a single i.m. dose of alpha-GPC in 12 normal volunteers. Citicoline (CTC), which also acts as a choline precursor, was included for comparison purposes. Each subject was studied on three randomized occasions, (i) in a control day in the absence of drug administration (to evaluate the plasma level profile of endogenous choline), (ii) after i.m. alpha-GPC (1,000 mg) and (iii) after i.m. CTC (1,000 mg) respectively, with a wash-out period of at least 1-week between sessions. Blood samples for plasma choline HPLC determinations were collected at regular intervals over a 6 h period. In the control session, plasma choline levels remained stable during the sampling period. The administration of alpha-GPC was associated with a rapid rise in plasma choline, peak levels being usually observed at the first (0.25 h) or second (0.5 h) sampling time after the injection. Thereafter, the concentration of choline declined gradually and returned to near baseline values at the end of the observation period. After the administration of CTC, plasma choline levels showed a similar time course but were considerably lower than those observed after the administration of alpha-GPC.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Choline/blood , Cytidine Diphosphate Choline/pharmacology , Glycerylphosphorylcholine/pharmacology , Adult , Cytidine Diphosphate Choline/administration & dosage , Glycerylphosphorylcholine/administration & dosage , Humans , Injections, Intramuscular , Male , Placebos
16.
Br J Clin Pharmacol ; 32(3): 335-40, 1991 Sep.
Article in English | MEDLINE | ID: mdl-1777370

ABSTRACT

1. The single dose pharmacokinetics of orally administered nimodipine (60 mg) were investigated in normal subjects and in two groups of epileptic patients receiving chronic treatment with hepatic microsomal enzyme-inducing anticonvulsants (carbamazepine, phenobarbitone or phenytoin) and sodium valproate, respectively. 2. Compared with the values found in the control group, mean areas under the plasma nimodipine concentration curve were lowered by about seven-fold (P less than 0.01) in patients taking enzyme-inducing anticonvulsants and increased by about 50% (P less than 0.05) in patients taking sodium valproate. 3. Nimodipine half-lives were shorter in enzyme-induced patients than in controls (3.9 +/- 2.0 h vs 9.1 +/- 3.4 h, means +/- s.d., P less than 0.01), but this difference could be artifactual since in the patients drug concentrations declined rapidly below the limit of assay, thus preventing identification of a possible slower terminal phase. In valproate-treated patients, half-lives (8.2 +/- 1.8 h) were similar to those found in controls.


Subject(s)
Anticonvulsants/pharmacology , Epilepsy/drug therapy , Nimodipine/pharmacokinetics , Valproic Acid/pharmacology , Adult , Drug Interactions , Enzyme Induction , Female , Half-Life , Humans , Male , Microsomes, Liver/enzymology , Nimodipine/therapeutic use
17.
Ital J Neurol Sci ; 12(3): 303-9, 1991 Jun.
Article in English | MEDLINE | ID: mdl-1874608

ABSTRACT

A multiparametric investigation of daytime sleepiness was performed in 18 healthy young university students. After undergoing a standard polysomnographic recording at home the night before, all subjects were evaluated by Multiple sleep latency test (MSLT) at 10.00, 12.00, 14.00, 16.00, 18.00. Subjective sleepiness (by using Visual Analogue Rating Scale) and performance tasks (Cancellation Test, Digit Symbol Substitution, Choice Reaction Time, Critical Flicker Fusion Threshold) were also assessed at the same times. Mean daily sleep latency was found to be about 10 minutes, with several individual values in the borderline range (greater than 5 less than 10 minutes). Subjects did not rate themselves as excessively sleepy and there was no correlation between subjective and objective estimates of sleepiness. No consistent correlation was found between subjective-objective sleepiness and results of performance tests. Anxiety trait (Spielberg State Anxiety Trait) did not correlate with sleepiness, but higher anxiety scores were significantly associated with poor performance. These results confirm the occurrence of fairly marked objective drowsiness in healthy young subjects which, however, was not associated with subjective sleepiness and did not adversely affect performance on a variety of tests of CNS function.


Subject(s)
Sleep/physiology , Adult , Female , Humans , Male , Neurophysiology , Neuropsychological Tests , Reaction Time , Reference Values
18.
Ital J Gastroenterol ; 23(5): 249-52, 1991 Jun.
Article in English | MEDLINE | ID: mdl-1742514

ABSTRACT

The effect of the natural flavonoid cyanidin (IdB 1027), 1200mg daily for 8 days, on the fall in gastric transmucosal potential difference induced by a single dose of aspirin (1000mg by nasogastric tube) was evaluated in 7 normal male volunteers. As compared to pretreatment values, IdB 1027 caused a significant reduction in both the percentage fall in transmucosal potential difference at the time of peak aspirin effect (from 37 +/- 18% to 18 +/- 5%, p less than 0.05) and the area under potential difference baseline (from 811 +/- 624 mvolt. min to 338 +/- 150 mvolt. min, p less than 0.05). These results provide evidence for a protecting effect of IdB 1027 against aspirin-induced gastric mucosal damage in man.


Subject(s)
Anthocyanins , Aspirin/pharmacology , Benzopyrans/pharmacology , Gastric Mucosa/physiology , Adult , Humans , Male , Membrane Potentials/drug effects
19.
Fundam Clin Pharmacol ; 5(4): 285-90, 1991.
Article in English | MEDLINE | ID: mdl-1916612

ABSTRACT

The plasma level profile of SA and SUA after a single oral dose of ASA was studied in 8 children with juvenile rheumatoid arthritis, aged 3.5-15.0 years. Pharmacokinetic parameters were on average similar to those reported in the literature for adult subjects, although a somewhat larger intersubject variability was found.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics , Arthritis, Juvenile/metabolism , Salicylates/pharmacokinetics , Adolescent , Anti-Inflammatory Agents, Non-Steroidal/blood , Anti-Inflammatory Agents, Non-Steroidal/urine , Arthritis, Juvenile/drug therapy , Child , Child, Preschool , Female , Hippurates/blood , Hippurates/pharmacokinetics , Hippurates/urine , Humans , Male , Salicylates/blood , Salicylates/urine , Salicylic Acid
20.
Article in English | MEDLINE | ID: mdl-1936066

ABSTRACT

The comparative pharmacokinetics and pharmacodynamics of single oral doses of eterobarbital (N,N'-dimethoxymethylphenobarbital, DMMP, 400 mg) and phenobarbital (200 mg) were evaluated in a double-blind study in 8 normal volunteers. Following administration of DMMP, no unchanged drug could be detected in serum. The active monomethoxymethyl metabolite (MMP) appeared rapidly in the circulation but its concentration remained generally low and declined below the limit of detection (0.5 micrograms/ml) usually before 9.5 h. Serum levels of DMMP-derived PB increased slowly and reached a peak between 24 and 48 h in most cases. One subject showed an atypical pharmacokinetic profile, characterized by relatively high levels of MMP and a delayed appearance of low levels of PB. After administration of PB, serum drug levels peaked within 1.5 h and remained, at all sampling times, higher than those observed after intake of DMMP. Compared with DMMP, PB induced greater sedative effects as assessed by visual analogue rating scale, critical flicker fusion frequency and multiple sleep latency tests.


Subject(s)
Phenobarbital/analogs & derivatives , Phenobarbital/pharmacokinetics , Administration, Oral , Adult , Chromatography, High Pressure Liquid , Double-Blind Method , Drug Combinations , Humans , Male , Metabolic Clearance Rate , Phenobarbital/administration & dosage , Phenobarbital/blood , Phenobarbital/pharmacology , Psychomotor Performance/drug effects , Sleep/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...